Pharma Services & Consumer Health · MARGIN
S&OP for SKU-Heavy Portfolios.
A planning cycle that holds service levels on less inventory, built for long SKU tails, customer-specific packs and constrained lines.
The problem this solves
- Forecasts rebuilt in spreadsheets every month, with bias nobody measures
- Service failures on the long tail while slow movers fill the warehouse
- Campaign and changeover plans that break when a priority order lands
What we measure
- Forecast accuracy and bias at SKU level
- On-time-in-full and service level
- Days of inventory and write-offs
Every program starts by baselining these numbers in your systems. Results are reported against your baseline, not against industry averages.
The playbook
01
Demand planning redesign
SKU-level statistical and machine-learning forecasting with bias tracking, using customer and retailer signals where they exist. Planners adjust by exception and own the number.
02
Portfolio and SKU rationalization
Margin and complexity cost by SKU, pack and customer, so the S&OP meeting can decide what to keep, consolidate or reprice.
03
Supply and capacity planning
Campaign sequencing, changeovers and materials tied to the demand plan, so capacity is allocated on margin and commitments rather than on whoever called last.
The market context, in published numbers
89%
of US prescriptions filled in 2025 were generics, which accounted for only 11.6% of total prescription drug spending
Association for Accessible Medicines, 2026 U.S. Generic & Biosimilar Medicines Savings Report (2026)
18%
of the 1,309 drug quality inspections in FDA's FY2025 report (1,248 FDA inspections plus 61 MRA partner inspections) were classified Official Action Indicated (OAI), the most serious outcome; US sites ran higher at 21.6%
12%
of nearly 10,000 FDA applications and supplements needing a facility assessment (received FY2024 to FY2025) got a Complete Response Letter because of facility withholds; FDA lists inadequate investigations and poorly documented quality-unit decisions among the citations behind them
20–50%
potential reduction in forecasting errors from applying AI-driven forecasting to supply chain management
Figures are third-party market benchmarks from the cited sources, not Ometz Partners client results. We share them so you can size the problem before we ever talk.
Capabilities
What the Operations Performance program covers.
Process measurement and redesign
Process mapping, work sampling and system logs to find where time, cost and errors accumulate, followed by a redesigned flow with clear ownership.
Order-to-cash and procure-to-pay
Emailed and PDF purchase orders read into the ERP, invoice matching, deduction and chargeback research, and collections prioritized by risk and value.
Revenue cycle operations
Eligibility, authorization preparation, claim edits and denial work queues for care providers, with root causes fed back to scheduling and intake.
S&OP and planning
A monthly sales and operations planning cycle with demand signals, capacity, inventory and service levels in one view, so plans hold between meetings.
Quality and regulatory documentation
Drafting and assembly of deviations, CAPA records, certificates of analysis, safety data sheets and specifications for review. Your Quality Unit reviews, approves and signs every GMP record.
Financial-services operations
Account opening and transfer paperwork, advisor onboarding files, fee billing and reconciliation, tax and audit engagement preparation, and alert-review preparation, with every decision left to your operations, principal and compliance staff.
Close, reconciliation and reporting
Month-end close tasks, reconciliations and management reports assembled automatically and checked against your controls.
Also in the Pharma Services & Consumer Health program
TECHNOLOGY
Quality Documentation Workbench
Cleaner quality records in less time: automation drafts, checks and assembles the documents, your Quality Unit reviews and signs, and release cycle time comes down.
REVENUE
Commercial Excellence: Proposals, Bids and Retail Plans
More of the right business at better prices: faster CDMO proposals, disciplined generics bids, and retailer plans for OTC brands built on real margin data.
Next step
Size this opportunity in your own numbers.
The Performance Diagnostic runs for two to four weeks at a fixed fee and ends with a baseline, three priced improvement plays and a 90-day plan. The findings are yours whether or not we continue.